Consensus Luye Pharma Group Ltd.

Equities

Market Closed - Hong Kong S.E. Other stock markets 04:09:00 2024-05-03 am EDT			5-day change	1st Jan Change
3.02 ^HKD	0.00%		+11.03%	-19.03%

Mar. 27	Luye Pharma Group Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Mar. 07	Luye Pharma Group Announces the Launch of Its Innovative Drug Zepzelca® (Lurbinectedin) for the Treatment of SCLC in Both Hong Kong and Macao	CI

68d5bd903.6A3ndHOFKp2LoC8sF2dse_oKNAruFjStOoZXg7J37EA.hVu2Ij3SQOnl6ldnRRIcSrkyY1LWO0GYYvE1sYBPpS68XqwzRcIf0d3BWA~90ca3a75d22ae5726d8766271ba78036

22-06-07

Sell

Buy

Mean consensus

UNDERPERFORM

Number of Analysts

Last Close Price

2.798 CNY

Average target price

2.785 CNY

Spread / Average Target

-0.47%

High Price Target

3.65 CNY

Spread / Highest target

+30.46%

Low Price Target

2.221 CNY

Spread / Lowest Target

-20.62%

Trading Rating

Investor Rating

ESG Refinitiv

B-